HER2+ circulating tumor cells (CTCs): a more sensitive and specific marker for CTCs positivity than total CTCs count in early breast cancer
Ignatiadis, M, Durbecq, V, Markowicz, S, Chaboteaux, C, Rouas, G, Mounia, B, Benjamin, B, Liebens, F, Georgoulias, V, Mavrudis, D, Piccart, M, Sotiriou, C
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article